Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders

Profenno, Louis A.; Porsteinsson, Anton P.; Faraone, Stephen V.

doi:10.1016/j.biopsych.2009.02.013

Cited by 718Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders

Open access

Profenno, Louis A., Porsteinsson, Anton P., Faraone, Stephen V.·2010·Biological Psychiatry

DOI 10.1016/j.biopsych.2009.02.013

Open this paper in CoChat — free account

Abstract

Background Late-onset Alzheimer's disease (AD) is a multifactorial and heterogeneous disorder with major risk factors including advanced age, presence of an apolipoprotein E epsilon4 (APOE4) allele, and family history of AD. Other risk factors may be obesity and diabetes and related disorders, which are highly prevalent.Methods We reviewed longitudinal epidemiological studies of body mass, diabetes, metabolic syndrome, and glucose and insulin levels on risk for AD. We conducted meta-analyses of the results from these studies.Results For obesity assessed by body mass index, the pooled effect size for AD was 1.59 (95% confidence interval [CI] 1.02-2.5; z = 2.0; p = .042), and for diabetes, the pooled effect size for AD was 1.54 (95% CI 1.33-1.79; z = 5.7; p < .001). Egger's test did not find significant evidence for publication bias in the meta-analysis for obesity (t = -1.4, p = .21) or for diabetes (t = -.86, p = .42). Since these disorders are highly comorbid, we conducted a meta-analysis combining all studies of obesity, diabetes, and abnormal glucose or insulin levels, which yielded a highly significant pooled effect size for AD of 1.63 (95% CI 1.39-1.92; z = 5.9; p < .001).Conclusions Obesity and diabetes significantly and independently increase risk for AD. Though the level of risk is less than that with the APOE4 allele, the high prevalence of these disorders may result in substantial increases in future incidence of AD. Physiological changes common to obesity and diabetes plausibly promote AD.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2009.02.013

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diabetes, hypertension, cardiovascular/renal/hepatic complications, hypogonadotropic hypogonadism, bronchial asthma, and Alzheimer's disease are associated with obesity.
“Several comorbidities such as diabetes, hypertension, cardiovascular/renal/hepatic complications, hypogonadotropic hypogonadism, bronchial asthma, and Alzheimer’s disease are associated with obesity [10-13].”
From Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects (2020) · cites this paper as [13]
Obesity and insulin resistance are significant risk factors for Alzheimer's disease.
“Obesity and insulin resistance are significant risk factors for Alzheimer’s disease [13] (Fig. 1).”
From Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects (2020) · cites this paper as [13]

Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · see citing works
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · see citing works
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works
ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
Woolf, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,739 · see citing works
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · see citing works
Adipocytes as regulators of energy balance and glucose homeostasis
Rosen, E. D., & Spiegelman, B. M. (2006) · Nature · doi:10.1038/nature05483 · Cited by 2,170 · see citing works
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · see citing works
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849 · see citing works
Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291 · see citing works
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258 · see citing works
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207 · see citing works
Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study
Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., et al. (1995) · Neurology · doi:10.1212/wnl.45.6.1161 · Cited by 829 · see citing works
An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease
Gustafson, D., Rothenberg, E., Blennow, K., Steen, B., & Skoog, I. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1524 · Cited by 811 · see citing works
Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study
Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., & Palumbo, P. J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009106 · Cited by 700 · see citing works
Hyperinsulinemia and risk of Alzheimer disease
Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683 · see citing works
Diabetes Mellitus and Risk of Alzheimer's Disease and Dementia with Stroke in a Multiethnic Cohort
Luchsinger, J. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.7.635 · Cited by 682 · see citing works
A 32-Year Prospective Study of Change in Body Weight and Incident Dementia: The Honolulu-Asia Aging Study
Stewart, R., Masaki, K., Xue, Q.-L., Peila, R., Petrovitch, H., White, L. R., & Launer, L. J. (2005) · Archives of Neurology · doi:10.1001/archneur.62.1.55 · Cited by 478 · see citing works
Body Mass Index in Midlife and Risk of Alzheimer Disease and Vascular Dementia
Whitmer, R., Gunderson, E., Quesenberry, C., Zhou, J., & Yaffe, K. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362047 · Cited by 430 · see citing works
Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men: The Honolulu-Asia Aging Study
Kalmijn, S., Foley, D., White, L., Burchfiel, C. M., Curb, J. D., Petrovitch, H., Ross, G. W., Havlik, R. J., & Launer, L. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2255 · Cited by 417 · see citing works
Diabetes mellitus and risk of dementia in the Kungsholmen project
Xu, W., Qiu, C., Wåhlin, Å., Winblad, B. G., & Fratiglioni, L. (2004) · Neurology · doi:10.1212/01.wnl.0000140291.86406.d1 · Cited by 409 · see citing works
Change in body mass index and risk of incident Alzheimer disease
Buchman, A. S., Wilson, R. S., Bienias, J. L., Shah, R. C., Evans, D. A., & Bennett, D. A. (2005) · Neurology · doi:10.1212/01.wnl.0000176061.33817.90 · Cited by 400 · see citing works
Intracerebroventricular insulin enhances memory in a passive-avoidance task
Park, C. R., Seeley, R. J., Craft, S., & WOODS, S. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00220-6 · Cited by 343 · see citing works
AMP-Activated Protein Kinase is Highly Expressed in Neurons in the Developing Rat Brain and Promotes Neuronal Survival Following Glucose Deprivation
Culmsee, C., monnig, J., Kemp, B. E., & Mattson, M. P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:1:45 · Cited by 340 · see citing works
Accelerated Weight Loss May Precede Diagnosis in Alzheimer Disease
Johnson, D. K., Wilkins, C. H., & Morris, J. C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.9.1312 · Cited by 339 · see citing works
Diabetes mellitus and the Risk of Dementia, Alzheimer’s Disease and Vascular Cognitive Impairment in the Canadian Study of Health and Aging
MacKnight, C., Rockwood, K., Awalt, E., & McDowell, I. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000064928 · Cited by 313 · see citing works
Obesity‐related leptin regulates Alzheimer's Aβ
Fewlass, D. C., Noboa, K., Pi‐Sunyer, F. X., Johnston, J. M., Yan, S. D., & Tezapsidis, N. (2004) · The FASEB Journal · doi:10.1096/fj.04-2572com · Cited by 308 · see citing works
Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia: The Cache County Study
Hayden, K. M., Zandi, P. P., Lyketsos, C. G., Khachaturian, A. S., Bastian, L. A., Charoonruk, G., Tschanz, J. T., Norton, M. C., Pieper, C. F., Munger, R. G., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213814.43047.86 · Cited by 293 · see citing works
Diabetes Mellitus and Risk of Developing Alzheimer Disease
Akomolafe, A., Beiser, A., Meigs, J. B., Au, R., Green, R. C., Farrer, L. A., Wolf, P. A., & Seshadri, S. S. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1551 · Cited by 281 · see citing works
Weight Loss Precedes Dementia in Community‐Dwelling Older Adults
Barrett-Connor, E. L., Edelstein, S. L., Corey‐Bloom, J., & Wiederholt, W. C. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01362.x · Cited by 266 · see citing works
Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease
Mattson, M. P., Barger, S. W., Furukawa, K., Bruce‐Keller, A. J., Wyss‐Coray, T., Mark, R. J., & Mucke, L. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00014-8 · Cited by 243 · see citing works
Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance
Curb, J. D., Rodríguez, B. L., Abbott, R. D., Petrovitch, H., Ross, G. W., Masaki, K., Foley, D. J., Blanchette, P. L., Harris, T. B., Chen, R., et al. (1999) · Neurology · doi:10.1212/wnl.52.5.971 · Cited by 231 · see citing works
Measures of Adiposity and Dementia Risk in Elderly Persons
Luchsinger, J. A., Patel, B. N., Tang, M., Schupf, N., & Mayeux, R. P. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.392 · Cited by 229 · see citing works
The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer’s Disease
Xu, W., Qiu, C., Winblad, B. G., & Fratiglioni, L. (2006) · Diabetes · doi:10.2337/db06-0879 · Cited by 218 · see citing works
Adiponectin Does Not Cross the Blood-Brain Barrier but Modifies Cytokine Expression of Brain Endothelial Cells
Spranger, J., Verma, S., Göhring, I., Bobbert, T., Seifert, J., Sindler, A. L., Pfeiffer, A. F. H., Hileman, S. M., Tschöp, M. H., & Banks, W. A. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-1077 · Cited by 217 · see citing works
Leptin and its role in hippocampal synaptic plasticity
HARVEY, J., SOLOVYOVA, N., & IRVING, A. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.03.001 · Cited by 202 · see citing works
Corticosteroids and Hippocampal Plasticity
McEwen, B. S. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb39223.x · Cited by 155 · see citing works
Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-β Peptide, Partial Restoration via γ-Secretase Inhibition
Han, B. H., Zhou, M.-L., Abousaleh, F., Brendza, R. P., Dietrich, H. H., Koenigsknecht-Talboo, J., Cirrito, J. R., Milner, E., Holtzman, D. M., & Zipfel, G. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4686-08.2008 · Cited by 138 · see citing works
The neurodegeneration mutant löchrig interferes with cholesterol homeostasis and Appl processing
Tschäpe, J., Hammerschmied, C., Mühlig‐Versen, M., Athenstaedt, K., Daum, G., & Kretzschmar, D. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf636 · Cited by 128 · see citing works
Association of Adiposity Status and Changes in Early to Mid-Adulthood With Incidence of Alzheimer's Disease
Beydoun, M. A., Lhotsky, A., Wang, Y., Forno, G. D., An, Y., Metter, E. J., Ferrucci, L., O’Brien, R., & Zonderman, A. B. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn229 · Cited by 108 · see citing works
Levothyroxin restores hypothyroidism-induced impairment of LTP of hippocampal CA1: Electrophysiological and molecular studies
Alzoubi, K. H., Gerges, N. Z., & Alkadhi, K. A. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.05.007 · Cited by 84 · see citing works
Interaction between interferon γ and insulin‐like growth factor‐1 in hippocampus impacts on the ability of rats to sustain long‐term potentiation
Maher, F. O., Clarke, R. M., Kelly, A. M., Nally, R. E., & Lynch, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03664.x · Cited by 81 · see citing works
Cerebral Small Vessel Disease-Induced Apolipoprotein E Leakage Is Associated With Alzheimer Disease and the Accumulation of Amyloid β-Protein in Perivascular Astrocytes
Utter, S., Tamboli, I. Y., Walter, J., Upadhaya, A. R., Birkenmeier, G., Pietrzik, C. U., Ghebremedhin, E., & Thal, D. R. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181836a71 · Cited by 79 · see citing works
Effects of estradiol benzoate on learning-memory behavior and synaptic structure in ovariectomized mice
Xu, X., & Zhang, Z. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.04.020 · Cited by 78 · see citing works
Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study
Sathiavageeswaran, M., Burman, P., Lawrence, D., Harris, A. G., Downing, M. G., Maruff, P. T., & Wass, J. A. H. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02346 · Cited by 65 · see citing works
Diabetes and overweight associate with non‐APOE4 genotype in an alzheimer's disease population
Profenno, L. A., & Faraone, S. V. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30694 · Cited by 39 · see citing works
Self-citation

Flagged first, then by citations

Sorted by citations

The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. S. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,668 · see citing works
Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · see citing works
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676 · see citing works
Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675 · see citing works
Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population‐based perspective
Baumgart, M., Snyder, H. M., Carrillo, M. C., Fazio, S., Kim, H., & Johns, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.016 · Cited by 1,660 · see citing works
Epidemiology of Alzheimer DiseasePreprint
Mayeux, R. P., & Stern, Y. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006239 · Cited by 1,070 · see citing works
Alzheimer’s disease: risk factors and potentially protective measures
Silva, M. V. F., Loures, C. D. M. G., Alves, L. C. V., de Souza, L. C., Borges, K. B. G., & Ferriani, M. D. G. C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0524-y · Cited by 962 · see citing works
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
Penninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839 · see citing works
Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies
Gudala, K., Bansal, D., Schifano, F., & Bhansali, A. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12087 · Cited by 727 · see citing works
A systematic literature review on obesity: Understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity
Safaei, M., Sundararajan, E. A., Driss, M., Boulila, W., & Shapi'i, A. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104754 · Cited by 720 · see citing works
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease
Pugazhenthi, S., Qin, L., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.017 · Cited by 697 · see citing works
Is Alzheimer’s disease a type 3 diabetes? A critical appraisal
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621 · see citing works
Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
Erickson, M. A., & Banks, W. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.135 · Cited by 572 · see citing works
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease
Nelson, A. R., Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.016 · Cited by 559 · see citing works
Epidemiology of Dementias and Alzheimer’s Disease
Sosa, A. L., Acosta, I., & Prince, M. J. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.11.003 · Cited by 553 · see citing works
Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions
Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 555 · see citing works
The relationship between obesity and cognitive health and decline
Dye, L., Boyle, N. B., Champ, C., & Lawton, C. (2017) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117002014 · Cited by 469 · see citing works
Body mass index and risk of dementia: analysis of individual-level data from 1·3 million individuals
Kivimäki, M., Luukkonen, R., Batty, G. D., Ferrie, J. E., Pentti, J., Nyberg, S. T., Shipley, M. J., Alfredsson, L., Fransson, E. I., Goldberg, M., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.016 · Cited by 440 · see citing works
Association Between Hypoglycemia and Dementia in a Biracial Cohort of Older Adults With Diabetes Mellitus
Yaffe, K. S. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.6176 · Cited by 434 · see citing works
Energy intake and exercise as determinants of brain health and vulnerability to injury and disease
Mattson, M. P. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.08.012 · Cited by 434 · see citing works
Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis
Santos, C. Y., Snyder, P. J., Wu, W., Zhang, M., Echeverria, A., & Alber, J. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.005 · Cited by 431 · see citing works
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Zheng, Q., & Wang, X. (2024) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 454 · see citing works
Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle–Aged Adults at Risk for Alzheimer Disease
Willette, A. A., Bendlin, B. B., Starks, E. J., Birdsill, A. C., Johnson, S. C., Christian, B. T., Okonkwo, O. C., La Rue, A., Hermann, B. P., Koscik, R. L., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0613 · Cited by 418 · see citing works
Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
Moore, E. M., Mander, A. G., Ames, D. J., Kotowicz, M. A., Carne, R. P., Brodaty, H., Woodward, M., Boundy, K. L., Ellis, K. A., Bush, A. I., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0229 · Cited by 405 · see citing works
An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer’s disease
Zhang, J., Chen, C., Hua, S., Liao, H., Wang, M., Xiong, Y., & Cao, F. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.024 · Cited by 376 · see citing works
Dietary phytochemicals and their potential effects on obesity: A review
González-Castejón, M., & Rodríguez‐Casado, A. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.07.004 · Cited by 375 · see citing works
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
Gold, M., Alderton, C., Zvartau-Hind, M., Egginton, S., Saunders, A. M., Irizarry, M., Craft, S., Landreth, G., Linnamägi, Ü., & Sawchak, S. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000318845 · Cited by 361 · see citing works
Risk factors associated with the onset and progression of Alzheimer's disease: a systematic review of the evidence
Hersi, M., Irvine, B., Gupta, P., Gomes, J., Birkett, N., & Krewski, D. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.03.006 · Cited by 332 · see citing works
Effects of the Insulin Sensitizer Metformin in Alzheimer Disease
Koenig, A. M., Mechanic-Hamilton, D. J., Xie, S. X., Combs, M., Cappola, A. R., Xie, L., Detre, J. A., Wolk, D. A., & Arnold, S. E. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000202 · Cited by 352 · see citing works
High Fat Diet Produces Brain Insulin Resistance, Synaptodendritic Abnormalities and Altered Behavior in Mice
Arnold, S., Lucki, I., Brookshire, B. R., Carlson, G., Browne, C., Kazi, H., Bang, S., Choi, B.-R., Chen, Y., McMullen, M. F., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.011 · Cited by 309 · see citing works
Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia
Yaffe, K., Falvey, C., Hamilton, N., Schwartz, A. V., Simonsick, E. M., Satterfield, S., Cauley, J. A., Rosano, C., Launer, L. J., Strotmeyer, E. S., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1117 · Cited by 313 · see citing works
The Therapeutic Potential of Metformin in Neurodegenerative Diseases
Rotermund, C., Machetanz, G., & Fitzgerald, J. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00400 · Cited by 310 · see citing works
Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
Li, X., Leng, S. X., & Song, D. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s74042 · Cited by 294 · see citing works
Sex biology contributions to vulnerability to Alzheimer's disease: a think tank convened by the Women's Alzheimer's Research Initiative
Snyder, H. M., Asthana, S., Bain, L., Brinton, R., Craft, S., Dubal, D. B., Espeland, M. A., Gatz, M., Mielke, M. M., Raber, J., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.08.004 · Cited by 262 · see citing works
Cognitive impairment and vitamin B12: a review
Moore, E. M., Mander, A. G., Ames, D. J., Carne, R. P., Sanders, K. M., & Watters, D. A. (2012) · International Psychogeriatrics · doi:10.1017/s1041610211002511 · Cited by 265 · see citing works
Obesity and ageing: Two sides of the same coin
Tam, B. T., Morais, J. A., & Santosa, S. (2020) · Obesity Reviews · doi:10.1111/obr.12991 · Cited by 254 · see citing works
Midlife and Late-Life Body Mass Index and Late-Life Dementia: Results from a Prospective Population-Based Cohort
Tolppanen, A., Ngandu, T., Kåreholt, I., Laatikainen, T. K., Rusanen, M., Soininen, H. S., & Kivipelto, M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130698 · Cited by 251 · see citing works
Effect of nutrition on neurodegenerative diseases. A systematic review
Bianchi, V. E., Herrera, P. F., & Rizzi, L. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1681088 · Cited by 258 · see citing works
Current and Emerging Drug Treatment Options for Alzheimerʼs Disease
Herrmann, N., Chau, S. A., Kircanski, I., & Lanctôt, K. L. (2011) · Drugs · doi:10.2165/11595870-000000000-00000 · Cited by 238 · see citing works
Insulin Reverses the High-Fat Diet–Induced Increase in Brain Aβ and Improves Memory in an Animal Model of Alzheimer Disease
Vandal, M., White, P. J., Tremblay, C., St‐Amour, I., Chevrier, G., Émond, V., Lefrançois, D., Virgili, J., Planel, E., Giguère, Y., et al. (2014) · Diabetes · doi:10.2337/db14-0375 · Cited by 232 · see citing works
High-fat diet-induced memory impairment in triple-transgenic Alzheimer’s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology.
Knight, E. M., Martins, I. V. A., Gümüsgöz, S., Allan, S. M., & Lawrence, C. B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.010 · Cited by 232 · see citing works
Microglia Play an Active Role in Obesity-Associated Cognitive Decline
Cope, E. C., LaMarca, E. A., Monari, P. K., Olson, L. B., Martinez, S., Zych, A. D., Katchur, N. J., & Gould, E. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0789-18.2018 · Cited by 225 · see citing works
Alterations in cholesterol metabolism as a risk factor for developing Alzheimer’s disease: Potential novel targets for treatment
Loera‐Valencia, R., Goikolea, J., Parrado‐Fernández, C., Merino‐Serrais, P., & Maioli, S. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.03.003 · Cited by 228 · see citing works
Is Alzheimer’s disease a systemic disease?
Morris, J. K., Honea, R. A., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.012 · Cited by 219 · see citing works
Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
Jiang, T., Yu, J., Tian, Y., & Tan, L. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990155 · Cited by 224 · see citing works
Obesity as a risk factor for Alzheimer's disease: weighing the evidence
Alford, S., Patel, D. K., Perakakis, N., & Mantzoros, C. S. (2017) · Obesity Reviews · doi:10.1111/obr.12629 · Cited by 219 · see citing works
Roles of β-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism
Pilozzi, A. R., Carro, C., & Huang, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010338 · Cited by 214 · see citing works
The Association Between Blood Pressure and Incident Alzheimer Disease: A Systematic Review and Meta-analysis
Power, M. C., Weuve, J., Gagne, J. J., McQueen, M. B., Viswanathan, A., & Blacker, D. (2011) · Epidemiology · doi:10.1097/ede.0b013e31822708b5 · Cited by 213 · see citing works
Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
Connell, E., Le Gall, G., Pontifex, M. G., Sami, S., Cryan, J. F., Clarke, G., Müller, M., & Vauzour, D. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00548-6 · Cited by 208 · see citing works
An update on type 2 diabetes, vascular dementia and Alzheimer’s disease.
Exalto, L. G., Whitmer, R. A., Kappele, L. J., & Biessels, G. J. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.07.014 · Cited by 194 · see citing works
Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline
Chornenkyy, Y., Wang, W., Wei, A. L., & Nelson, P. T. (2018) · Brain Pathology · doi:10.1111/bpa.12655 · Cited by 184 · see citing works
Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism
Vercruysse, P., Vieau, D., Blum, D., Petersén, Å., & Dupuis, L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00002 · Cited by 172 · see citing works
Glycation exacerbates the neuronal toxicity of β-amyloid
Li, X.-H., Du, L.-L., Cheng, X.-S., Jiang, X., Zhang, Y., Lv, B.-L., Liu, R., Wang, J.-Z., & Zhou, X.-W. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.180 · Cited by 178 · see citing works
Midlife Hypertension and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Lennon, M. J., Makkar, S. R., Crawford, J. D., & Sachdev, P. S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190474 · Cited by 176 · see citing works
Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions
Solas, M., Milagro, F. I., Ramírez, M. J., & Martínez, J. A. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.10.005 · Cited by 173 · see citing works
Enhanced neural activation with blueberry supplementation in mild cognitive impairment
Boespflug, E. L., Eliassen, J. C., Dudley, J. A., Shidler, M. D., Kalt, W., Summer, S. S., Stein, A. L., Stover, A. N., & Krikorian, R. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1287833 · Cited by 171 · see citing works
The Complex Interactions Between Obesity, Metabolism and the Brain
Uranga, R. M., & Keller, J. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00513 · Cited by 166 · see citing works
“New Old Pathologies”: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS)
Nelson, P. T., Trojanowski, J. Q., Abner, E. L., Al-Janabi, O. M., Jicha, G. A., Schmitt, F. A., Smith, C. D., Fardo, D. W., Wang, W.-X., Kryscio, R. J., et al. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw033 · Cited by 158 · see citing works
Novel Roles for the Insulin-Regulated Glucose Transporter-4 in Hippocampally Dependent Memory
Pearson-Leary, J., & McNay, E. C. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1700-16.2016 · Cited by 158 · see citing works
Sex Differences in Alzheimer’s Disease
Aggarwal, N. T., & Mielke, M. M. (2023) · Neurologic Clinics · doi:10.1016/j.ncl.2023.01.001 · Cited by 170 · see citing works
Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis
Zhou, M., Xu, R., Kaelber, D. C., & Gurney, M. E. (2020) · PLOS ONE · doi:10.1371/journal.pone.0229819 · Cited by 157 · see citing works
Crosstalk between obesity, diabetes, and alzheimer’s disease: Introducing quercetin as an effective triple herbal medicine
Ebrahimpour, S., Zakeri, M., & Esmaeili, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101095 · Cited by 158 · see citing works
Environment and Gene Association With Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases
Flores-Dorantes, M. T., Díaz‐López, Y. E., & Gutiérrez‐Aguilar, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00863 · Cited by 159 · see citing works
Amyloid Precursor Protein and Proinflammatory Changes Are Regulated in Brain and Adipose Tissue in a Murine Model of High Fat Diet-Induced Obesity
Puig, K. L., Floden, A. M., Adhikari, R., Golovko, M. Y., & Combs, C. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030378 · Cited by 152 · see citing works
Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies
Atti, A. R., Valente, S., Iodice, A., Caramella, I., Ferrari, B., Albert, U., Mandelli, L., & Ronchi, D. D. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.01.214 · Cited by 153 · see citing works
Can Infections Cause Alzheimer's Disease?
Mawanda, F., & Wallace, R. B. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs007 · Cited by 151 · see citing works
Potential benefits of adherence to the Mediterranean diet on cognitive health
Féart, C., Samieri, C., Allès, B., & Barberger‐Gateau, P. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112002959 · Cited by 149 · see citing works
“Cell Membrane Theory of Senescence” and the Role of Bioactive Lipids in Aging, and Aging Associated Diseases and Their Therapeutic Implications
Das, U. N. (2021) · Biomolecules · doi:10.3390/biom11020241 · Cited by 142 · see citing works
Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer’s disease
Broce, I. J., Tan, C. H., Fan, C. C., Jansen, I., Savage, J. E., Witoelar, A., Wen, N., Hess, C. P., Dillon, W. P., Glastonbury, C. M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1928-6 · Cited by 140 · see citing works
Brain Insulin Resistance in Alzheimer's Disease and its Potential Treatment with GLP-1 Analogs
Talbot, K. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.73 · Cited by 139 · see citing works
The nature, significance, and glucagon‐like peptide‐1 analog treatment of brain insulin resistance in Alzheimer's disease
Talbot, K., & Wang, H.-Y. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.007 · Cited by 140 · see citing works
AMPK: A cellular metabolic and redox sensor. A minireview
Shirwany, N. A. (2014) · Frontiers in bioscience · doi:10.2741/4218 · Cited by 142 · see citing works
Alzheimer's Disease in Down Syndrome.
Head, E., Powell, D. K., Gold, B. T., & Schmitt, F. A. (2012) · PubMed · Cited by 139 · see citing works
Adolescent obesity and dietary decision making—a brain-health perspective
Lowe, C. J., Morton, J. B., & Reichelt, A. C. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(19)30404-3 · Cited by 141 · see citing works
Midlife Vascular Risk Factors and Alzheimer's Disease: Evidence from Epidemiological Studies
Tolppanen, A., Solomon, A., Soininen, H. S., & Kivipelto, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120802 · Cited by 134 · see citing works
Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer’s disease by exendin-4
Chen, S., Liu, A., An, F.-M., Yao, W., & Gao, X. (2011) · AGE · doi:10.1007/s11357-011-9303-8 · Cited by 136 · see citing works
Glycolytic Metabolism, Brain Resilience, and Alzheimer’s Disease
Zhang, X., Alshakhshir, N., & Zhao, L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.662242 · Cited by 134 · see citing works
Therapeutic strategies for tau mediated neurodegeneration
Yoshiyama, Y., Lee, V. M. ‐., & Trojanowski, J. Q. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303144 · Cited by 129 · see citing works
Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?
Kawamura, T., Umemura, T., & Hotta, N. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00234.x · Cited by 128 · see citing works
β-Alanyl-L-Histidine Rescues Cognitive Deficits Caused by Feeding a High Fat Diet in a Transgenic Mouse Model of Alzheimer's Disease
Herculano, B., Tamura, M., Ohba, A., Shimatani, M., Kutsuna, N., & Hisatsune, T. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121324 · Cited by 127 · see citing works
Is obesity a brain disease?
Shefer, G., Marcus, Y., & Stern, N. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.07.015 · Cited by 124 · see citing works
Genetic architecture of epigenetic and neuronal ageing rates in human brain regions
Lu, A. T.-H., Hannon, E. J., Levine, M. E., Crimmins, E. M., Lunnon, K., Mill, J. S., Geschwind, D. H., & Horvath, S. (2017) · Nature Communications · doi:10.1038/ncomms15353 · Cited by 125 · see citing works
A large scale multivariate parallel ICA method reveals novel imaging–genetic relationships for Alzheimer's disease in the ADNI cohort
Meda, S. A., Narayanan, B., Liu, J., Perrone‐Bizzozero, N. I., Stevens, M. C. G., Calhoun, V. D., Glahn, D. C., Shen, L., Risacher, S. L., Saykin, A. J., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.12.076 · Cited by 119 · see citing works
Hyperphosphorylation of Tau Induced by Naturally Secreted Amyloid-β at Nanomolar Concentrations Is Modulated by Insulin-dependent Akt-GSK3β Signaling Pathway
Tokutake, T., Kasuga, K., Yajima, R., Sekine, Y., Tezuka, T., Nishizawa, M., & Ikeuchi, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348300 · Cited by 117 · see citing works
Microbiota intestinal y salud
Álvarez, J., Fernández‐Real, J. M., Guarner, F., Gueimonde, M., Rodríguez, J. M., de Pipaón, M. S., & Sanz, Y. (2021) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2021.01.009 · Cited by 135 · see citing works
Modulation of Mitochondrial Complex I Activity Averts Cognitive Decline in Multiple Animal Models of Familial Alzheimer's Disease
Zhang, L., Zhang, S., Maezawa, I., Trushin, S., Minhas, P. S., Pinto, M., Jin, L., Prasain, K., Nguyen, T. D. T., Yamazaki, Y., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.03.009 · Cited by 110 · see citing works
Common Mechanisms of Alzheimer's Disease and Ischemic Stroke: The Role of Protein Kinase C in the Progression of Age-Related Neurodegeneration
Lucke-Wold, B. P., Turner, R. C., Logsdon, A. F., Simpkins, J. W., Alkon, D. L., Smith, K. E., Chen, Y., Tan, Z. T., Huber, J. D., & Rosen, C. L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141422 · Cited by 112 · see citing works
Human cognitive function and the obesogenic environment
Martin, A., & Davidson, T. L. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.02.062 · Cited by 113 · see citing works
The Cognitive Control of Eating and Body Weight: It’s More Than What You “Think”
Davidson, T. L., Jones, S., Roy, M., & Stevenson, R. J. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.00062 · Cited by 114 · see citing works
Increased Risk of Dementia in Patients with Antidepressants: A Meta-Analysis of Observational Studies
Wang, Y., Tai, P.-A., Poly, T. N., Islam, M. M., Yang, H., Wu, C.-C., & Li, Y. (2018) · Behavioural Neurology · doi:10.1155/2018/5315098 · Cited by 111 · see citing works
Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, β-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of Alzheimer's disease
Walker, J. M., Dixit, S., Saulsberry, A. C., May, J. M., & Harrison, F. E. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.01.004 · Cited by 110 · see citing works
Genetic Variants in the Fat and Obesity Associated (FTO) Gene and Risk of Alzheimer's Disease
Reitz, C., Tosto, G., Mayeux, R. P., Luchsinger, J. A., & the NIA-LOAD/NCRAD Family Study Group and the Alzheimer's Disease Neuroimaging Initiative (2012) · PLoS ONE · doi:10.1371/journal.pone.0050354 · Cited by 109 · see citing works
Menopause, obesity and inflammation: interactive risk factors for Alzheimer’s disease
Christensen, A., & Pike, C. J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00130 · Cited by 108 · see citing works
Healthy brain, healthy life: a review of diet and exercise interventions to promote brain health and reduce Alzheimer’s disease risk
Baranowski, B. J., Marko, D. M., Fenech, R. K., Yang, A. J. T., & MacPherson, R. E. K. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2019-0910 · Cited by 109 · see citing works
The complex relationship between obesity and neurodegenerative diseases: an updated review
Neto, A., Fernandes, A. M. A., & Barateiro, A. P. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1294420 · Cited by 113 · see citing works
Effects of adiposity and metabolic dysfunction on cognition: A review
Farruggia, M. C., & Small, D. M. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112578 · Cited by 112 · see citing works
Cinnamon, a promising prospect towards Alzheimer’s disease
Momtaz, S., Hassani, S., Khan, F., Ziaee, M., & Abdollahi, M. R. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.011 · Cited by 106 · see citing works
Macro- and Microstructural Magnetic Resonance Imaging Indices Associated With Diabetes Among Community-Dwelling Older Adults
Falvey, C., Rosano, C., Simonsick, E. M., Harris, T. B., Strotmeyer, E. S., Satterfield, S., Yaffe, K. S., & Study, F. T. H. A. (2012) · Diabetes Care · doi:10.2337/dc12-0814 · Cited by 105 · see citing works
Gut microbes and health
Álvarez, J., Fernández‐Real, J. M., Guarner, F., Gueimonde, M., Rodríguez, J. M., de Pipaon, M. S., & Sanz, Y. (2021) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2021.01.002 · Cited by 109 · see citing works
Age‐dependent impairment of glucose tolerance in the 3xTg‐AD mouse model of Alzheimer's disease
Vandal, M., White, P. J., Chevrier, G., Tremblay, C., St‐Amour, I., Planel, E., Marette, A., & Calon, F. (2015) · The FASEB Journal · doi:10.1096/fj.14-268482 · Cited by 103 · see citing works

DEFAULT NETWORK AND MEDIAL PREFRONTAL CORTEX DYSFUNCTION IN SCHIZOPHRENIA AND IN FIRST DEGREE RELATIVES OF PERSONS WITH SCHIZOPHRENIA
Seidman, L. J., Whitfield, S., Thermenos, H. W., Rosso, I. M., Makris, N., Milanovic, S. M., Goldstein, J. M., Gabrieli, J. D. E., Faraone, S. V., & Tsuang, M. T. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.198 · Cited by 1 · see citing works
Self-citation
A brief summary of the articles appearing in this issue of Biological Psychiatry
(2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.018
Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease
Martins, I. J., Hone, E., Foster, J. K., Sünram-Lea, S. I., Gnjec, A., Fuller, S. J., Nolan, D., Gandy, S. E., & Martins, R. N. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001854 · Cited by 388 · see citing works
Association between diabetes mellitus and risk of Alzheimer’s disease: a meta-analysis and systematic review
Wu, J., Li, J., Qin, X., & Chen, W. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1736410 · Cited by 5 · see citing works
Diabetes and overweight associate with non‐APOE4 genotype in an alzheimer's disease population
Profenno, L. A., & Faraone, S. V. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30694 · Cited by 39 · see citing works
Self-citation

Authors: Profenno, L. A., Porsteinsson, A. P., & Faraone, S. V.
Affiliations: SUNY Upstate Medical University (US)
University of Rochester Medicine (US)
Corresponding author: Profenno, Louis A.
ORCID: Porsteinsson, Anton P.
Faraone, Stephen V.
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 2010-03
Volume: 67
Issue: 6
Pages: 505-512
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/j.biopsych.2009.02.013
OpenAlex: W2032605307
Cited by: 718
References: 45
Citations by year: 2026: 19 · 2025: 41 · 2024: 55 · 2023: 51 · 2022: 44 · 2021: 47 · 2020: 55 · 2019: 65 · 2018: 39 · 2017: 43 · 2016: 41 · 2015: 52 · 2014: 50 · 2013: 46 · 2012: 44
FWCI: 2.84
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
SUNY Digital Repository Support (State University of New York System) (submittedVersion, cc-by-nc-nd)
Funders: U.S. Department of Veterans Affairs
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: Alzheimer's disease, obesity, diabetes mellitus, metabolic syndrome, body mass index, glucose concentration, insulin levels, disease risk factors, APOE ε4, comorbidities
MeSH terms: Aged, Alzheimer Disease, Female, Glucose, Humans, Insulin, Longitudinal Studies, Male, Mental Status Schedule, Middle Aged, Obesity, Retrospective Studies, Risk Factors, Body Mass Index, Proportional Hazards Models, PubMed, Diabetes Complications, Overweight, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks